Ledger.Open graph →
SEC Form D · filed October 4, 2022

Sensorium Therapeutics, Inc

Offering
$24.8M
Sold
$15.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Ryan Katz · Atlanta, GADirectorPranav Tadi · Waltham, MAExecJerrold Rosenbaum · Waltham, MADirectorRichard Simon · New York, NYExec · DirectorKevin Lalande · Austin, TXDirectorRyan Katz · Rockville, MDDirectorPranav Tadi · Waltham, MAExecJerrold Rosenbaum · Waltham, MADirectorRichard Simon · Waltham, MAExec · DirectorKevin Lalande · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗